Furosemide is aloop diureticused to treatfluid retention(edema) in people with congestiveheart failure, liver disease, or a chronic kidney disorder such as nephrotic syndrome. Furosemide is also used to treathigh blood pressure(hypertension). ...
Consider providing bridge therapy with a medication to treat acute headaches and optimizing a preventative regimen to avoid rebound headache (Boes 2006; Garza 2019).Dosage adjustment for concomitant therapy: Significant drug interactions exist, requiring dose/frequency adjustment or avoidance. Consult drug...
Chinese Nursing ResearchTian Shan,Li Hanqun,Huangshi Maternal and Child Health-Care Hospital of Hubei Province,,.Study on wet compress with different drugs to treat patients with postpartum perineal injury edema.[J];Chinese Nursing Research,2014-04...
water retention and weight gain. Less common but serious effects include anemia, bone fractures, heart issues, liver failure and macular edema. These drugs can affect how genes work, leading to different side effects for each drug.
According to recent studies, migraine affects more than 1 billion people worldwide, making it one of the world’s most prevalent diseases. Although this highly debilitating illness has been known since ancient times, the first therapeutic drugs to treat migraine, ergotamine (Gynergen) and dihydroerg...
Another substance on which high expectations were placed following initial studies was the selective alpha7-nAChR partial agonist, ABT-126. In a phase II study, ABT-126 significantly improved cognition in the intent-to-treat population. Further analysis of subgroups revealed that the beneficial effect...
High doses of VC have been used for influenza treatments for a very long time;13–17 CsA has also been used to treat non-organ-transplantation-associated pneumonia;68 Celecoxib and Mesalazine (two prescription drugs) successfully cured mice infected with H5N1;26 and Ulinastatin has a good ...
After using lixisenatide to treat 6068 T2DM patients with recent coronary events, the ELIXA (Evaluation of Lixisenatide in Acute Coronary Syndrome) trial (NCT01147250) found that lixisenatide could slow down the progression of UACR in patients who have massive albuminuria, reduce the probability of ...
The side effect of ARIA-edema occurred in 22% of the participants in both groups. TRAILBLAZER-ALZ 5 (NCT05508789) is being conducted to assess the safety and efficacy of donanemab in individuals with early symptomatic AD. The trial started in October 2022; 1,500 participants will be ...
Trikafta is used to treat adults and children aged 2 years and older with cystic fibrosis (CF) with at least one copy of the F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or another mutation responsive to treatme